evodiamine has been researched along with Hyperlipemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, L; Ni, H; Ren, F; Ren, J; Shen, T; Wei, H; Wei, J; Xu, S; Zhou, X | 1 |
Ching, LC; Kou, YR; Lee, HF; Lee, TS; Shyue, SK; Wei, J; Zhao, JF | 1 |
2 other study(ies) available for evodiamine and Hyperlipemia
Article | Year |
---|---|
Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats.
Topics: Administration, Oral; Animals; Apolipoprotein B-48; Berberine; Body Weight; Cholesterol, LDL; Coptis; Diet, High-Fat; Drug Combinations; Evodia; Gene Expression Regulation; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lipid Metabolism; Liver; Male; Membrane Transport Proteins; Quinazolines; Rats; Rats, Sprague-Dawley; Sitosterols; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Triglycerides | 2017 |
Essential role of transient receptor potential vanilloid type 1 in evodiamine-mediated protection against atherosclerosis.
Topics: Animals; Apolipoproteins E; Blotting, Western; Coronary Artery Disease; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fatty Liver; Hyperlipidemias; Male; Mice; Mice, Knockout; Quinazolines; TRPV Cation Channels | 2013 |